The pharma terms behind data-first AI, in plain English.
EU-GMP, ALCOA+, CSV, Annex 11 — the vocabulary of regulated manufacturing decides whether an AI initiative survives an audit. Here's what each term means, and why it matters when the data comes first.
GxP
The umbrella term for the quality regulations governing regulated industries — GMP (manufacturing), GLP (laboratory), GCP (clinical) and GDP (distribution). Being “GxP” means your processes, records and systems meet the applicable regulatory standard and can prove it under audit.
Why it matters for data-first AI — Any AI that touches a GxP record inherits GxP obligations — it has to be validated, controlled and auditable, not just accurate.
GMP
The regulations ensuring medicines and medical devices are consistently produced and controlled to quality standards appropriate to their intended use — covering facilities, equipment, materials, personnel, process control and records.
Why it matters for data-first AI — GMP is a data problem as much as a process one: without traceable, controlled data you cannot prove the product was made correctly.
EU-GMP
The EU’s GMP framework, published as EudraLex Volume 4 and enforced by the EMA and national authorities. For manufacturers exporting into the EU it is the market-access gate — and its Annex 11 governs computerised systems specifically. A GMP finding can stop a shipment.
Why it matters for data-first AI — For an export-ambitious plant, EU-GMP is the bar every AI and data system must clear before it can support release.
ALCOA+
The data-integrity principles regulators expect every GxP record to satisfy. ALCOA = Attributable, Legible, Contemporaneous, Original, Accurate. The “+” adds Complete, Consistent, Enduring and Available. In plain terms: you must be able to prove who did what, when, on the original data — and keep it retrievable for the record’s full lifetime.
Why it matters for data-first AI — An AI output is only as defensible as the ALCOA+ data underneath it. Get the fabric right and the same evidence that trains the model also passes the audit.
Data integrity
The assurance that data is complete, consistent and accurate across its entire lifecycle — the foundation of GxP trust. Regulators (MHRA, FDA, WHO, PIC/S) have made it a top inspection focus, and a data-integrity finding is one of the most common reasons an export stalls.
Why it matters for data-first AI — Data-first means fixing integrity at the source — so AI is built on records that survive an inspection, not spreadsheets that don’t.
EU Annex 11
The EU-GMP annex governing computerised systems — covering validation, data, access control, audit trails, electronic signatures and change control. Any system touching GMP records in the EU market must satisfy it.
Why it matters for data-first AI — AI systems in a GMP plant are computerised systems under Annex 11 — validation and audit-trail requirements apply from day one.
21 CFR Part 11
The US FDA regulation on electronic records and electronic signatures — the American counterpart to EU Annex 11. It sets the requirements for trustworthy, auditable electronic records in FDA-regulated environments.
Why it matters for data-first AI — If you also supply the US market, electronic records from an AI system have to meet Part 11 alongside Annex 11.
CSV / CSA
CSV is the documented process of proving a computerised system does what it should — reliably and compliantly. CSA is the FDA’s newer, risk-based evolution of CSV, focusing validation effort where product and patient risk is highest rather than testing everything equally.
Why it matters for data-first AI — We build validation into delivery from the start (CSA-aware), rather than bolting a validation exercise onto a finished AI project.
Electronic Batch Record (EBR)
The digital version of the batch manufacturing record — the complete, auditable history of how a specific batch was made. EBRs replace paper travellers and are what make “review by exception” possible.
Why it matters for data-first AI — Structured EBR data is prime fuel for AI: it’s already traceable to batch, step and operator.
LIMS
The system that manages sample, test and result data in the QC laboratory — a primary source of quality data.
Why it matters for data-first AI — A key source system to unify into a data-integrity fabric alongside production data.
MES
The shop-floor system that dispatches, tracks and records production against the order — sitting between enterprise planning (ERP) and the equipment.
Why it matters for data-first AI — MES is where production reality lives; connecting it is essential to compute cross-domain KPIs.
Process historian
The time-series database that captures equipment and process signals — temperatures, pressures, speeds, alarms — at high frequency.
Why it matters for data-first AI — The raw material for predictive maintenance and OEE; historian data is where equipment failure signatures hide.
Batch review by exception
A quality-release approach where the system surfaces only the deviations and out-of-spec events that need a human decision, instead of re-reading every in-spec record — cutting review time while keeping QA accountable for the call.
Why it matters for data-first AI — One of the highest-value pharma AI use cases: grounded reasoning over the EBR, with QA firmly in the loop.
Deviation & CAPA
A deviation is any departure from an approved procedure or specification. CAPA is the governed process of investigating it and preventing recurrence.
Why it matters for data-first AI — AI helps surface, triage and trend deviations — so investigations start faster and patterns don’t get missed.
Sovereign / on-prem AI
AI deployed inside the plant’s own firewall — on-premises or at the edge — so sensitive process IP and regulated data never leave the site.
Why it matters for data-first AI — For pharma this addresses IP protection and data-residency obligations by architecture, not by policy — the sovereignty half of the pharma equation.
These definitions are plain-English summaries. The governing references are the EU GMP guidelines (EudraLex, Volume 4) including Annex 11; the US FDA 21 CFR Part 11; the MHRA ‘GXP’ Data Integrity Guidance; PIC/S PI 041 on data integrity; and WHO good-practices guidance. Always validate against the current text of the applicable regulation for your market.
Now put it to work.
See how these principles become a sovereign, audit-defensible AI stack — on the Pharma & Medtech vertical page.